Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 DPT Labs, Imprimis in Clinical Supply Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

DPT Labs, Imprimis in Clinical Supply Pact

To provide topical anti-inflammatory drug for Phase III trials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Imprimis Pharmaceuticals, Inc. and DPT Labs have entered an agreement under which DPT will supply Imprimis with quantities of its active topical anti-inflammatory drug, Impracor, for Phase III trials. Impracor is the first drug to be developed using Imprimis’s Accudel topical delivery technology.

Imprimis Pharmaceuticals, Inc. chief executive officer, Mark L. Baum said, “Imprimis is pleased to have entered into an agreement for manufacturing our active Impracor clinical supplies from DPT Labs, a worldwide leader in the contract formulation and production of semi-solid pharmaceutical products. We are very confident that choosing DPT Labs will provide Imprimis with the best semi-solid production capabilities in the United States and the flexibility of scale to manufacture Impracor. The DPT agreement means that Imprimis is one step closer to our goal to get Impracor approved for sale and into the hands of patients who are suffering from musculoskeletal pain and inflammatory conditions.”

 “We are delighted to be chosen by Imprimis and we look forward to leveraging our expertise in semi-solids and liquids to support further execution of clinical development and manufacturing strategies for Impracor,” said Paul Josephs, DPT senior vice president sales, marketing and corporate development.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics